Current Report Filing (8-k)
April 14 2020 - 3:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
April 14, 2020
Bio-En Holdings Corp.
(Exact Name of Registrant as Specified in
its Charter)
Delaware
|
|
333-186629
|
|
990369776
|
(State of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
1 County Road, Unit B
Secaucus, NJ 07094
(Address of principal executive offices)
(845) 364-7151
(Registrant’s telephone number, including
area code)
(Former Name or former address if changed
from last report.)
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which
registered
|
|
|
|
|
|
None
|
|
|
|
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging Growth Company x
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 1.01 Material Definitive Agreement.
On November 29, 2019, Bio-En Holdings Corp.
(“Bio”) announced that it had entered into a binding term sheet (the “Term Sheet”) to merge with Leo Riders
Company (“Leo”), pursuant to which Leo would become a wholly-owned subsidiary of Bio with shares of Bio common stock
being issued to the shareholders of Leo in an amount equal to up to 40% of the post-transaction outstanding capital stock of Bio.
According to the Term Sheet Bio would provide
interim financing to Leo and assist Leo in additional capital raising efforts.
Pursuant to the Term Sheet, prior to December
31, 2019, Bio transferred to Leo aggregate sums equal to $235,000.
However, due to certain information regarding
the financial position of Leo, which has come to light since the announcement of the Term Sheet, Bio has informed Leo that it is
terminating the Term Sheet, and the merger with Leo is not expected to take place. Bio is taking steps to recover from Leo the
monies it has advanced to date.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
April 14, 2020
Bio-En Holdings Corp
|
|
|
|
|
|
|
|
/s/ Barry Adika
|
|
By:
|
Barry Adika
|
|
Title:
|
Chief Executive Officer
|
|
Bio En (CE) (USOTC:BENH)
Historical Stock Chart
From Apr 2024 to May 2024
Bio En (CE) (USOTC:BENH)
Historical Stock Chart
From May 2023 to May 2024